Skip to main content

Bone-marrow cells repair ischaemic legs

Autologous implantation of bone marrow mononuclear cells could treat chronic limb ischaemia

Written byTudor Toma
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00

Lower limb ischaemia results from narrowing of the arteries in the leg and causes persistently recurring rest pain, ulceration and in the most severe cases gangrene of the foot. Currently little can be done to open or regenerate the blood vessels that have deteriorated to this extent. In August 10 The Lancet, Eriko Tateishi-Yuyama and colleagues at the Kansai Medical University, Osaka, Japan, show that autologous implantation of bone marrow mononuclear cells could be an effective method of therapeutic angiogenesis, by harnessing the ability of marrow cells to supply endothelial progenitor cells (Lancet 2002, 360:427-435).

Following up a pilot study on 25 patients with unilateral leg ischaemia, Tateishi-Yuyama et al. performed a randomized double blind study on a further 22 patients with bilateral leg ischaemia. These patients were randomly injected with bone marrow mononuclear cells in one leg and peripheral blood-mononuclear cells or saline in the other as a control. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Improving rAAV Production for Viral Vector Manufacturing

Improving rAAV Production for Viral Vector Manufacturing

cytiva logo
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Scientist holding a clear 384-well PCR microplate in a laboratory

What Dictates PCR Success Before Amplification Begins?

Integra Logo
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems

Products

Sino Biological Logo

Sino Biological Launches European Newsletter Campaign with Exclusive Welcome Gifts

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo